help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laferrère, B.
Right arrow Articles by Bowers, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laferrère, B.
Right arrow Articles by Bowers, C. Y.
Related Collections
Right arrow Obesity
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 2 611-614
Copyright © 2005 by The Endocrine Society

RAPID COMMUNICATION

Growth Hormone Releasing Peptide-2 (GHRP-2), Like Ghrelin, Increases Food Intake in Healthy Men

Blandine Laferrère, Cynthia Abraham, Colleen D. Russell and Cyril Y. Bowers

Obesity Research Center (B.L., C.A., C.D.R.), St. Luke’s Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, 1090 Amsterdam Avenue, New York, New York 10025; and Tulane University Health Sciences Center (C.Y.B.), New Orleans, Louisiana 70112

Address all correspondence and requests for reprints to: Colleen Russell, St. Luke’s Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, New York 10025. E-mail: cr2054{at}columbia.edu

Abstract

GHRP-2 is a synthetic agonist of ghrelin, the newly-discovered gut peptide which binds to the growth hormone (GH) secretagogue receptor. Ghrelin has two major effects, stimulating both GH secretion and appetite/meal initiation. GHRP-2 has been extensively studied for its utility as a growth hormone secretagogue (GHS). Animal studies have shown its effect on food intake. However, whether GHRP-2 can also stimulate appetite in humans when administered acutely is not known. We subcutaneously infused 7 lean, healthy males with GHRP-2 (1 µg/kg/h) or saline for 270 minutes and then measured their intake of an ad libitum, buffet-style meal. Similar to what has been reported for ghrelin administration, our subjects ate 35.9 ± 10.9% more when infused with GHRP-2 vs. saline, with every subject increasing their intake even when calculated per kg body weight (136.0 ± 13.0 kJ/kg [32.5 ± 3.1 kcal/kg] vs. 101.3 ± 10.5 kJ/kg [24.2 ± 2.5 kcal/kg], p = 0.008). The macronutrient composition of consumed food was not different between conditions. As expected, serum GH levels rose significantly during GHRP-2 infusion (AUC 5550 ± 1090 µg/L/240 min vs. 412 ± 161 µg/L/240 min, p = 0.003). These data are the first to demonstrate that GHRP-2, like ghrelin, increases food intake, suggesting that GHRP-2 is a valuable tool for investigating ghrelin effects on eating behavior in humans.

Received August 30, 2004.

Accepted October 26, 2004.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Strassburg, S. D. Anker, T. R. Castaneda, L. Burget, D. Perez-Tilve, P. T. Pfluger, R. Nogueiras, H. Halem, J. Z. Dong, M. D. Culler, et al.
Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E78 - E84.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
K. Chihara, A. Shimatsu, N. Hizuka, T. Tanaka, Y. Seino, Y. Katofor, and the KP-102 Study Group
A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency
Eur. J. Endocrinol., July 1, 2007; 157(1): 19 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
G. A. Bray and F. L. Greenway
Pharmacological Treatment of the Overweight Patient
Pharmacol. Rev., June 1, 2007; 59(2): 151 - 184.
[Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
S. Perboni and A. Inui
Anorexia in cancer: role of feeding-regulatory peptides
Phil Trans R Soc B, July 29, 2006; 361(1471): 1281 - 1289.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Y. Bowers
Octanoyl Ghrelin Is Hypothalamic Rooted
Endocrinology, June 1, 2005; 146(6): 2508 - 2509.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laferrère, B.
Right arrow Articles by Bowers, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laferrère, B.
Right arrow Articles by Bowers, C. Y.
Related Collections
Right arrow Obesity

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals